|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | TP or Not TP: Primary mediators in a close runoff? 显示文摘 | Pratico D Cheng Y Fitz Gerald GA | 2000 | Arterioscler Thromb Vasc Biol2000，20，7： | 1 |
| 2 | Oxidative stress and cardiovascular injury partⅠ:basic mechanisms and in vivo monitoring of ROS显示文摘 | Griendling KK Fitz Gerald GA | 2003 | Circulation2003，108，16： | 1 |
| 3 | Parecoxib, valdecoxib,and cardiovascular risk显示文摘 | Furberg CD Psaty BM Fitz Gerald GA | 2005 | Circulation2005，111，3： | 1 |
| 4 | Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities 显示文摘 | Grosser T Fries S Fitz GA | 2006 | Clin Invest2006，116，1： | 1 |
| 5 | Circadian clocks and vascular function显示文摘 | Paschos GK Fitz Gerald GA | 2010 | Circulat Res2010，106，5： | 1 |
| 6 | Platelet-aetive drugs : the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy 显示文摘 | Patrono C OHer B Fitz Gerald GA | 2004 | Chest2004，126，： | 1 |
| 7 | Parsing an enigma: the pharmacodynamics of aspirin resistance 显示文摘 | Fitz Gerald GA | 2003 | Lancet2003，361，9357： | 1 |
| 8 | Mechanisms of platelet activation: thromboxane A2 as an amplifying signal for other agonists显示文摘 | Fitz Gerald GA | 1991 | Am J Cardiol1991，68，： | 1 |
| 9 | Cigarette smoking and hemostatic function显示文摘 | Fitz Gerald GA Oates JA Nowak J | 1988 | Am Heart J1988，115，： | 1 |
| 10 | Parecoxib, valdecoxib, and cardiovascular risk显示文摘 | Furberg CD Psaty BM Fitz Gerald GA | 2005 | Circulation2005，111，3： | 1 |
| 11 | Biosynthesis of thromboxane A2 in renovascular hypertension显示文摘 | Fitz Greald GA Fitz Greald DJ | 1984 | JAMA1984，251，23： | 1 |
| 12 | Oxidative stress and cardiovascular injury:Part II:Animal and human tudies显示文摘 | Griendling KK Fitz Gerald GA | 2003 | Circulation2003，108，： | 1 |
| 13 | TP or Not TP:Primary mediators in a close runoff显示文摘 | Cheng Y Fitz Gerald GA | 2000 | Arterioscler Thromb Vasc Biol2000，20，7： | 1 |
| 14 | Oxidative stress and cardiovascular injury:Part I:basic mechanisms and in vi-vo monitoring of ROS显示文摘 | Griendling KK Fitz Gerald GA | 2003 | Circulation2003，108，： | 1 |
| 15 | Platelet active drugs: the relationships among dose, effectiveness, and side effects 显示文摘 | Patrono C Coller B Fitz Gerald GA | 2004 | Chest2004，126，3： | 1 |
| 16 | Coxibs and cardiovascular disease显示文摘 | Fitz Gerald GA | 2004 | N Engl J Med2004，351，： | 1 |
| 17 | Platelet active drugs: the relationships among does, effectiveness, and side effects:the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy显示文摘 | Patrono C Coller B Fitz Gerald GA | 2004 | Chest2004，126，3： | 1 |
| 18 | Platelet-active drugs:the relationships among dose,effecfiveness,and side effects:the seventh Ac-CP conference on antithrombotic and thrombolytic therapy显示文摘 | Patrono C Coller B Fitz Gerald GA | 2004 | Chest2004，126，3： | 1 |
| 19 | TP or Not TP: Primary mediators in a close runoff显示文摘 | Cheng Y Fitz Gerald GA | 2000 | Arterioscler Thromb Vasc Biol2000，20，： | 1 |
| 20 | Oxidative stress and cardiovascular injury part Ⅱ:animal and human studies显示文摘 | Griendling KK Fitz Gerald GA | 2003 | Circulation2003，108，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员